title: Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy.
authors.affiliation: Department of Ophthalmology, Hospital Clínic de Barcelona, Calle Sabino de Arana, s/n, 08028, Barcelona, Spain. alforja@clinic.ub.es.
authors.forename: María Socorro
authors.initials: MS
authors.lastname: Alforja
authors.affiliation: Department of Ophthalmology, Hospital Clínic de Barcelona, Calle Sabino de Arana, s/n, 08028, Barcelona, Spain.
authors.forename: Noelia
authors.initials: N
authors.lastname: Sabater
authors.affiliation: Department of Ophthalmology, Hospital Clínic de Barcelona, Calle Sabino de Arana, s/n, 08028, Barcelona, Spain.
authors.forename: Joan
authors.initials: J
authors.lastname: Giralt
authors.affiliation: Department of Ophthalmology, Hospital Clínic de Barcelona, Calle Sabino de Arana, s/n, 08028, Barcelona, Spain.|Instituto de Microcirugía Ocular, Barcelona, Spain.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Adán
authors.affiliation: Department of Ophthalmology, Hospital Clínic de Barcelona, Calle Sabino de Arana, s/n, 08028, Barcelona, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: Pelegrín
authors.affiliation: Department of Ophthalmology, Hospital Clínic de Barcelona, Calle Sabino de Arana, s/n, 08028, Barcelona, Spain.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Casaroli-Marano
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D012162:Retinal Degeneration / Q000175:diagnosis / Q000188:drug therapy*; D012166:Retinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy*; D058471:Subretinal Fluid; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity; D014823:Vitreous Hemorrhage / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab